Skip to main content
. 2020 Jan 23;15(2):247–256. doi: 10.2215/CJN.08970719

Figure 4.

Figure 4.

Clinical outcomes of patients who achieve complete remission of rFSGS are comparable with patients who did not experience recurrence. Comparison of levels of (A) proteinuria and (B) eGFR calculated by Modification of Diet in Renal Disease Study (MDRD) in patients without recurrence with patients with recurrent FSGS (rFSGS) stratified by their response to treatment. eGFR after graft loss was imputed with a value of 5 ml/min per 1.73 m2. Error bars represent SEMs.